Nurix Therapeutics (NRIX) Amortizatization of Intangibles (2020 - 2026)

Nurix Therapeutics (NRIX) has 7 years of Amortizatization of Intangibles data on file, last reported at $1.6 million in Q2 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 42.35% year-over-year to $1.6 million in Q2 2026; TTM through May 2026 was $7.6 million, a 43.53% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, down 8.56% from the prior year.
• Amortizatization of Intangibles for Q2 2026 stood at $1.6 million, down from $2.0 million in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for NRIX reached as high as $3.7 million in Q3 2024 and fell as low as -$542000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.7 million across 5 years, with a median of $1.9 million in 2024.
• Across the five-year window, Amortizatization of Intangibles slumped 144.14% in 2022 and soared 2081.93% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $650000.0 in 2022, then soared by 202.77% to $2.0 million in 2023, then soared by 77.49% to $3.5 million in 2024, then tumbled by 46.55% to $1.9 million in 2025, then dropped by 16.6% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.6 million in Q2 2026, $2.0 million in Q1 2026, and $1.9 million in Q4 2025.